HomeCompareREMI vs ORCC

REMI vs ORCC: Dividend Comparison 2026

REMI yields 285714.29% · ORCC yields 9.79%● Live data

vsPost on X →
After 10 years · $10,000 invested · DRIP enabled
🏆 REMI wins by $1.734986541242196e+31M in total portfolio value
10 years
REMI
REMI
● Live price
285714.29%
Share price
$0.00
Annual div
$2.00
5Y div CAGR
0%
Payout ratio
50%
After 10 yrs · $10,000 · DRIP
Portfolio value
$1.734986541242196e+31M
Annual income
$17,337,928,197,276,910,000,000,000,000,000,000,000.00
Full REMI calculator →
ORCC
ORCC
● Live price
9.79%
Share price
$13.48
Annual div
$1.32
5Y div CAGR
-50%
Payout ratio
50%
After 10 yrs · $10,000 · DRIP
Portfolio value
$21.4K
Annual income
$1.04
Full ORCC calculator →

Portfolio growth — REMI vs ORCC

📍 REMI pulled ahead of the other in Year 1

Annual dividend income

🛡️

Recession Test — Did They Cut Dividends?

How each stock treated shareholders during the 3 biggest crises of the last 20 years

Crisis PeriodREMIORCC
2008–2009
GFC
— No data— No data
2020 Q1–Q2
COVID
— No data— No data
2022 Q4
Rate Hike
— No data— No data
Based on dividend payment history. "Increased" = dividend grew during crisis. "Maintained" = held within 3%. "Cut" = reduced by more than 3%.
📅

Dividend Calendar Overlap

Combined, REMI + ORCC cover 0 of 12 monthsgood coverage

Jan
Feb
Mar
Apr
May
Jun
Jul
Aug
Sep
Oct
Nov
Dec
REMI pays
ORCC pays
Both pay
Neither
💰

Tax Bracket Optimizer

Which stock is actually better after tax? Adjust your rate to find out.

REMI
Annual income on $10K today (after 15% tax)
$24,285,714.29/yr
After 10yr DRIP, annual income (after tax)
$14,737,238,967,685,373,000,000,000,000,000,000,000.00/yr
ORCC
Annual income on $10K today (after 15% tax)
$832.34/yr
After 10yr DRIP, annual income (after tax)
$0.88/yr
At 15% tax rate, REMI beats the other by $14,737,238,967,685,373,000,000,000,000,000,000,000.00/year in after-tax income after 10 years on $10,000
⚖️

Lazy Portfolio Split Optimizer

What's the optimal mix of REMI + ORCC for your $10,000?

REMI: 50%ORCC: 50%
100% ORCC50/50100% REMI
Portfolio after 10yr
$8.67493270621098e+30M
Annual income
$8,668,964,098,638,455,000,000,000,000,000,000,000.00/yr
Blended yield
99.93%
📊

Analyst Conviction Gap

Where Wall Street is most bullish on ORCC right now

REMI
No analyst data
Altman Z
-5.7
Piotroski
4/9
ORCC
Analyst Ratings
9
Buy
4
Hold
1
Sell
Consensus: Buy
Price Target
$16.00
+18.7% upside vs current
Range: $16.00 — $16.00
Altman Z
0.5
Piotroski
5/9
Analyst ratings via FMP. Altman Z-Score: >3.0 safe, 1.81–3.0 grey zone, <1.81 distress. Piotroski: 7–9 strong, 0–3 weak.
🏛️

Copy Congress — What Are Politicians Buying?

Senate & House STOCK Act disclosures (last 90 days)

REMI buys
0
ORCC buys
0
No recent congressional trades found for REMI or ORCC in the last 90 days.
STOCK Act mandates disclosure within 45 days of transaction. Data via FMP.Full tracker →
MetricREMIORCC
Forward yield285714.29%9.79%
Annual dividend / share$2.00$1.32
Payout ratio50%50%
1-year div growth0%0%
5-year div CAGR0%-50%
Portfolio after 10y$1.734986541242196e+31M$21.4K
Annual income after 10y$17,337,928,197,276,910,000,000,000,000,000,000,000.00$1.04
Total dividends collected$1.734908400352195e+31M$1.0K
Payment frequencyquarterlyquarterly
SectorStockBDC

Year-by-year: REMI vs ORCC ($10,000, DRIP)

YearREMI PortfolioREMI Income/yrORCC PortfolioORCC Income/yrGap
1← crossover$28,582,129$28,571,428.57$11,190$489.61+$28.57MREMI
2$76,351,353,429$76,320,770,551.21$12,229$256.01+$76351.34MREMI
3$190,619,493,207,524$190,537,797,259,355.30$13,216$130.74+$190619493.19MREMI
4$444,781,927,427,195,200$444,577,964,569,463,100.00$14,207$66.02+$444781927427.18MREMI
5$969,967,353,346,567,200,000$969,491,436,684,220,000,000.00$15,234$33.17+$969967353346567.13MREMI
6$1,976,961,629,315,093,000,000,000$1,975,923,764,247,012,300,000,000.00$16,317$16.62+$1976961629315092992.00MREMI
7$3,765,923,944,594,039,000,000,000,000$3,763,808,595,650,671,000,000,000,000.00$17,468$8.32+$3.765923944594039e+21MREMI
8$6,704,681,437,057,684,000,000,000,000,000$6,700,651,898,436,968,000,000,000,000,000.00$18,695$4.16+$6.704681437057683e+24MREMI
9$11,156,275,836,497,016,000,000,000,000,000,000$11,149,101,827,359,364,000,000,000,000,000,000.00$20,006$2.08+$1.1156275836497015e+28MREMI
10$17,349,865,412,421,960,000,000,000,000,000,000,000$17,337,928,197,276,910,000,000,000,000,000,000,000.00$21,407$1.04+$1.734986541242196e+31MREMI

REMI vs ORCC: Complete Analysis 2026

REMIStock

Remedent, Inc., through its subsidiaries, researches, designs, develops, manufactures, and distributes oral care and cosmetic dentistry products. It primarily provides professional veneers and teeth whitening products for professional and over-the-counter use. The company offers River8, a prefab veneer that enables the dentist to find the right combination of teeth for a patient with minor reshaping. It also provides GlamSmile veneers, which are ultra-thin claddings attached to the front of the patient's teeth. In addition, the company offers SmileMe Mirror, an integrated marketing concept for the dental practice, which enables dentists to offer smile consultation in approximately 10 minutes; SmileSketch, a simulation software to make a sketch of what the patient could look like; and various Treatment Pages to explain the benefits of certain treatments, as well as Condor, an intra-oral 3D scanner. Further, it provides dental implant solutions and treatment concepts. The company sells its products to dental professionals in approximately 30 countries, including Asia, Europe, the Middle East, Canada, and the United States through its internal sales force and third party distributors. The company was founded in 1986 and is headquartered in Ghent, Belgium.

Full REMI Calculator →

ORCCBDC

Owl Rock Capital Corporation is a business development company. The fund makes investments in senior secured or unsecured loans, subordinated loans or mezzanine loans and also considers equity-related securities including warrants and preferred stocks also pursues preferred equity investments and common equity investments. Within private equity, it seeks to invest in growth, acquisitions, market or product expansion, refinancings and recapitalizations. It seeks to invest in middle market companies based in the United States, with EBITDA between $10 million and $250 million annually and/or annual revenue of $50 million and $2.5 billion at the time of investment.

Full ORCC Calculator →
📬

Get this REMI vs ORCC comparison by email

Save your analysis + weekly dividend insights. Free forever.

More comparisons

REMI vs SCHDREMI vs JEPIREMI vs OREMI vs KOREMI vs MAIN

⚠️ Educational purposes only. Not financial advice. Congressional trades sourced from SEC STOCK Act filings via FMP. Past performance does not guarantee future results.